0
ARTICLE |

OVARIAN HILUS CELL (LEYDIG CELL) HYPERPLASIA ASSOCIATED WITH MASCULINIZATION

ISABEL TALIAFERRO, M.D.; EDWIN J. WELLS, M.D.; SAUL KAY, M.D.; RANDOLPH H. HOGE, M.D.
AMA Arch Intern Med. 1953;91(5):675-684. doi:10.1001/archinte.1953.00240170101007.
Text Size: A A A
Published online

OVARIAN tumors which are known to produce masculinization have usually been classified as arrhenoblastomas of the ovary, adrenal-like tumors of the ovary, and luteomas. The relationship of these tumors to each other, especially as regards histogenesis, morphology, and endocrine function, is a matter of continuing discussion, but these relationships remain unsettled. Teilum1 has emphasized the need for an improved histogenetic and morphologic classification of these and other functioning ovarian neoplasms.

Another ovarian lesion associated with virilization, namely, hyperplasia or tumor of ovarian hilus cells, has recently been studied by Sternberg2 and discussed by Schiller.3 The ovarian hilus cells have been called sympathicotropic cells, ovarian Leydig cells, ovarian interstitial cells, and extraglandular Leydig cells; they are morphologically indistinguishable from testicular interstitial cells of Leydig (which produce androgen in the male) and are considered to be a possible source of ovarian androgen.2

Cases of tumor of ovarian hilus cells have been reported

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();